OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA
Mediterranean Journal of Hematology and Infectious Diseases · 31.10.2026 · 18 (1) · e2026086
DOI: 10.4084/mjhid.2026.086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediterranean Journal of Hematology and Infectious Diseases, online erschienen am 31.10.2026. Verfasst von Adriano Venditti und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The management of acute myeloid leukemia (AML) in elderly or unfit patients has undergone a paradigm shift with the integration of molecular diagnostics and targeted therapies. Among actionable alterations, IDH1 mutations define a biologically distinct subgroup for which ivosidenib combined with azacitidine has recently emerged as a standard of care. However, initial clinical management remains complex. Three main themes emerged from the expert panel’s discussion: all patients should be tested for IDH1m, with turnaround time of 3-5 days; adequate patient monitoring during treatment is essential to detect the earliest signs of differentiation syndrome and QTc prolongation; appropriate management of concomitant therapies is required, not only for azole derivatives administered for antifungal prophylaxis, where need. This paper provides a comprehensive and evidence-based framework for optimizing early management in unfit patients with newly diagnosed IDH1-mutated AML, integrating data from randomized trials, real-world studies, and updated evidence on antifungal prophylaxis and drug–drug interactions in the era of targeted therapies.
Zitieren
APA
Venditti, A., Riva, M., Pagano, L., Marconi, G., Fracchiolla, N., Danesi, R., Curti, A., Candoni, A., Borlenghi, E., & Voso, M. T. (2026). OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026086. https://doi.org/10.4084/mjhid.2026.086
Vancouver
Venditti A, Riva M, Pagano L, Marconi G, Fracchiolla N, Danesi R, et al. OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases. 2026;18(1):e2026086. doi:10.4084/mjhid.2026.086
BibTeX
@article{Venditti2026,
author = {Venditti, Adriano and Riva, Marta and Pagano, Livio and Marconi, Giovanni and Fracchiolla, Nicola and Danesi, Romano and Curti, Antonio and Candoni, Anna and Borlenghi, Erika and Voso, Maria Teresa},
title = {OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA},
journal = {Mediterranean Journal of Hematology and Infectious Diseases},
year = {2026},
volume = {18},
number = {1},
pages = {e2026086},
doi = {10.4084/mjhid.2026.086}
}
EUVIMED